UNSPSC 51373008: Phenazocine hydrobromide

This classification denotes an opioid analgesic and narcotic C22H27NO.BrH, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier C1749020IH, chemically known as 2'-hydroxy-5,9-dimethyl-2-phenethyl-6,7-benzomorphan, hbr, but more generally known as phenazocine hydrobromide, which bears US NIH Compound Identifier 14706. European Medicines Agency schedules Phenazocine hydrobromide in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB03734MIG.

Most nations, for tariff and trade purposes, schedule phenazocine hydrobromide under HS 29333999 and SITC 51574. As of Q4 2014, PHENAZOCINE HYDROBROMIDE remains US FDA's Preferred Term for this commodity. Phenazocine hydrobromide bears US NLM identifiers UMLS ID C0600121 and NCI Concept Code C96729. SMILES: C[C@H]1[C@H]2CC3CCC(CC3[C@@]1(CCN2CCC4CCCCC4)C)O.BR.

UNSPSC 51373008 Phenazocine hydrobromide is a Commodity code; the single recent state and local opportunity posted under it does not align with the code's pharmaceutical scope. Seminole County, Florida released IFB 60459723LAS in June 2026 seeking procurement of naloxone and safe drug deactivation systems—public health and harm-reduction equipment, not phenazocine—indicating either miscoding or a data-source mismatch. The work that state and local governments actually buy under this code cannot be reliably characterized from available recent solicitation activity.

No additional representative opportunities or issuing-body patterns emerge from the source to support a meaningful geographic spread or procurement frequency assessment. The code shows minimal visible recent activity in state and local markets; practitioners should verify UNSPSC coding accuracy and monitor for future postings to establish whether phenazocine procurement activity exists or whether this code remains dormant in state and local contracting.